
We were honoured to interview leading cancer pathologist and CEO of Protean BioDiagnostics, Dr. Anthony Magliocco, to discuss key insights from his incredible wealth of experience working in the field of pathology and precision cancer medicine.
Dr. Magliocco is a board-certified Pathologist and Professor of Oncology and Pathology with over 30 years of experience in tissue pathology, medical research, molecular diagnostics, liquid biopsy, genetics, digital image analysis and clinical trials.
You’ll come away with inspiring information on new cancer care advancements that are providing patients with far better outcomes than what is being offered in standard care – and a better understanding of how to access these new tools.
Watch the interview with Dr. Magliocco and Precision Cancer Medicine Patient Educator and Advocate, Michelle Morand.
What You’ll Learn in This Video
→ Who is Dr. Anthony Magliocco, MD?
→ How Tony became involved with cancer care
→ The importance of lifestyle and early screening
→ Why Tony founded Protean in 2017
→ The giant gap between standard cancer care and the newest science
→ Why ‘precision’ is the key to cancer care
→ Pathology as the foundation of medicine
→ The inequality of healthcare
→ Moving away from a one-size-fits-all model
→ Dealing with the shortage of pathologists
→ Innovative technologies on the horizon
→ The need for interdisciplinary treatment teams
→ Key takeaways on how to access better cancer care
Knowledge is Power!
We know that receiving a cancer diagnosis can be scary and stressful for anyone. We’re here to help you understand what all of your precision medicine cancer treatment options are and which genetic tests and imaging you need to get, so you can make the best decision for your health.
Turn Hope into Reality
If you’d like to learn more about what’s possible for you in cancer care today, reach out and take the next step:
✓ Join our free online program, “Cancer: Just the Facts”
✓ Book a Free Cancer Care Consultation
✓ Get a Complete Treatment Options Review with Alex Rolland
Reach out anytime if you have questions. We’re here to support you.
on December 20, 2024